entertainment -WSS

entertainment

author：entertainment 2025-08-12 09:12:32 - browse：14

Medical illustration of Streptococcus pneumoniae bacteria — A medical illustration of drug-resistant, Streptococcus pneumoniae bacteria. Antibiotic Resistance Coordination and Strategy Unit/CDC

Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature paper, published in 2020, that suggested these microbes are consistently found in tumors, and that they create such specific signatures they could be used to identify cancer types with nearly 100% accuracy.

But late Monday night, a team of researchers published a manuscript on the preprint site bioRxiv.com showing what they believe to be two “fatal errors” in the Nature paper’s analyses, invalidating not only the paper’s findings but possibly the scientific foundation for Micronoma, which has raised an estimated $17.5 million in funding from investors including SymBiosis Capital Management and the Seerave Foundation.

One allegation is that the Nature paper’s authors didn’t adequately filter out human DNA from their database of tumor samples, leading them to incorrectly classify millions of human sequences as bacterial. The other is that a separate error led the team’s algorithm to find false associations between specific microbial signatures and cancer types.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Element Biosciences CEO lays out genome sequencing strategy

hotspot

WSS

Orangutan used medicinal plant to treat wound, first time ever seen

How to pay for weight loss drugs and save Medicare

Pediatric cancer treatments threatened by a new FDA policy

Rep. Raul Ruiz on the physician shortage and more

UnitedHealth’s Optum accused of antitrust violations in California

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

hotspot

entertainment

focus

23andMe had bad news about my health. I wish a person had delivered it

Dogs on Prozac: What pet anti

The high cost of giving birth even with insurance

Why rehabilitation engineers need to center patients in their research

Supreme Court strikes down use of affirmative action

Cancer researcher Catriona Jamieson is sending tumors into space

After affirmative action ruling, medical educators look to 'holistic review'

Fetal surgery at risk from Dobbs and new abortion restrictions

Dobbs anniversary: the lost opportunity of abortion as health care

Why does health care cost so much? A reading guide

hotspot

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

UnitedHealth financials solid despite Change Healthcare cyberattack

30 years of 'Listening to Prozac'

Fetal surgery at risk from Dobbs and new abortion restrictions

Flagship Pioneering launches a new biotech in two countries

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

focus

hotspot

focus

focus